导致心力衰竭的萨尔科佩尼亚的分子机制
1Acute Medicine Section, Division of Medicine, Louis Stokes Cleveland Veteran Affairs Medical Center, Cleveland, OH 44106, USA.
概括
麻症或与年龄相关的肌肉损失在心力衰竭 (HF) 患者中很常见,并且与不良结果有关. 了解分子联系可能会揭示新的疗法,以防止这种不断增长的人群的肌肉损耗.
科学领域:
- 老年学是一门学科.
- 心脏病学 心脏病学
- 肌肉生理学 肌肉生理学
背景情况:
- 皮症是一种与衰老相关的骨肌肉疾病,不成比例地影响心力衰竭 (HF) 患者.
- 患有肉症的HF患者的临床结果比一般HF患者差.
- 预计,随着全球人口老龄化,HF中肉类的患病率将增加.
研究的目的:
- 探索在HF患者中萨尔科佩尼亚患病率增加背后的分子机制.
- 讨论潜在的治疗策略,以向涉及萨尔科佩尼亚和高频率的分子信号.
主要方法:
- 本综述综合了当前关于连接肉症和高血压的分子途径的研究.
- 它检查了关于心脏功能障碍背景下肌肉损失病理生理学的新兴证据.
主要成果:
- 多种机制性途径有助于高频率肺炎患者的高发病率.
- 这些途径涉及心脏功能障碍和骨肌肉分子信号之间的复杂相互作用.
- 了解这些分子信号对于开发有针对性的干预措施至关重要.
结论:
- 迫切需要新的治疗策略,以改善沙科佩尼亚HF患者的治疗结果.
- 针对特定的分子机制为预防或治疗这种群体的肌肉损失提供了一个有希望的途径.
- 需要进一步研究HF和肉症之间的分子联系.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
Pathophysiology of Cardiac Performance
649
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
649
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


